The possibility that our entire universe merely exists inside a computer simulation is more than an idle science fiction ...

By any measure, there is an enormous number of programming languages. Some lists contain hundreds, while the Historical ...

For consumers, however, the incentives look weaker. Credit cards offer rich rewards programs, while deposits and money-market funds pay interest. By contrast, the GENIUS Act explicitly prohibits ...

Learn how Claude's ability to monitor its internal states could transform AI safety and provide insights into human brain ...

But stablecoin's future might hinge on whether it becomes mainstream digital money for low-cost payments or a tool for a growing universe of risky leveraged finance. For widespread stablecoin adoption ...

The U.S. private credit market has reached $2.1 trillion in assets under management (AUM) this year, surpassing the ...

In some cases, incentives designed to drive adoption could even push stablecoins into riskier territory, encouraging people ...

A new physics study challenges the simulation hypothesis, arguing that the universe contains realities that can likely never ...

AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...

Recursion's approach is intriguing, as evidenced by the fact that several of the world's largest pharmaceutical companies ...

Recursion CEO Chris Gibson is out after 12 years as the ambitious "techbio" company positions itself for its next phase of AI drug discovery.

Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...